ERYPED 400 MG/5 ML SUSPENSION

Erythromycin Ethylsuccinate
$6.3072per ML

Strength

400 mg/5mL

NDC

24338013013

Classification

Brand

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

1/22/2025

Active Ingredients

ERYTHROMYCIN ETHYLSUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA050207

On Market Since

6/14/2012

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-0.6%

5Y

-0.6%

All

+258.7%